123 related articles for article (PubMed ID: 1290126)
1. [Thermotherapy in oncology].
Di Palma M; Jasmin C; Nagi M; Sidi J; Tsamas A; Vannetzel JM
Soins; 1992 Nov; (566):6-8. PubMed ID: 1290126
[No Abstract] [Full Text] [Related]
2. [Hyperthermia. A new therapeutic possibility in oncology makes special demands on nurses].
Wacker-Riedt I; Schäfers-Schulte H
Pflege Z; 1997 Apr; 50(4):171-7. PubMed ID: 9220817
[No Abstract] [Full Text] [Related]
3. [Hyperthermia in cancer treatment].
Neuwirth J
Dtsch Krankenpflegez; 1990 May; 43(5):359-64. PubMed ID: 2116292
[No Abstract] [Full Text] [Related]
4. [Is laser-induced thermotherapy (LITT) advisable for neoplastic diseases?].
Wiedemann GJ; Feyerabend T
Dtsch Med Wochenschr; 2002 Feb; 127(6):286. PubMed ID: 11832990
[No Abstract] [Full Text] [Related]
5. Nursing management of the patient receiving local or regional hyperthermia.
Moore CL
Oncol Nurs Forum; 1984; 11(3):40-3. PubMed ID: 6562636
[No Abstract] [Full Text] [Related]
6. [Hyperthermia methods in oncology].
Lopatin VF; Kliuch VE
Med Radiol (Mosk); 1983 Sep; 28(9):71-7. PubMed ID: 6353122
[No Abstract] [Full Text] [Related]
7. Minimally invasive thermotherapy method for tumor treatment based on an exothermic chemical reaction.
Deng ZS; Liu J
Minim Invasive Ther Allied Technol; 2007; 16(6):341-6. PubMed ID: 17943608
[TBL] [Abstract][Full Text] [Related]
8. Quality assessment and assurance in clinical hyperthermia: requirements and procedures.
Nussbaum GH
Cancer Res; 1984 Oct; 44(10 Suppl):4811s-4817s. PubMed ID: 6467234
[TBL] [Abstract][Full Text] [Related]
9. Palliative care and oncology: growing better together.
Byock I
J Clin Oncol; 2009 Jan; 27(2):170-1. PubMed ID: 19064951
[No Abstract] [Full Text] [Related]
10. [Potential possibilities and perspectives for using oligonucleotides in clinical oncology].
Ratajczak MZ; Skorski T
Pol Tyg Lek; 1991 Dec 2-9; 46(48-49):913-7. PubMed ID: 1845706
[No Abstract] [Full Text] [Related]
11. Hyperthermia as a treatment for neoplasia.
Dreznik A; Falk RE; Howard V; Makowka L; Venturi D
Can J Surg; 1982 Nov; 25(6):603-8. PubMed ID: 6754046
[TBL] [Abstract][Full Text] [Related]
12. CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials.
Hammond AL; Waller EK; Finkelstein LB
J Clin Oncol; 2007 Apr; 25(10):1288; author reply 1288. PubMed ID: 17401022
[No Abstract] [Full Text] [Related]
13. Disclosure of financial conflicts of interest by authors publishing in the Journal of Clinical Oncology.
Go RS; Mathiason MA; Lee JA
J Clin Oncol; 2008 Jan; 26(3):509-10; author reply 510-1. PubMed ID: 18202429
[No Abstract] [Full Text] [Related]
14. Incorporation of geriatric principles in oncology clinical trials.
Hurria A
J Clin Oncol; 2007 Dec; 25(34):5350-1. PubMed ID: 18048814
[No Abstract] [Full Text] [Related]
15. Phase 0 clinical studies in oncology.
Collins JM
Clin Pharmacol Ther; 2009 Feb; 85(2):204-7. PubMed ID: 19109589
[No Abstract] [Full Text] [Related]
16. [Principle status and strategy of medical oncology].
Shi Y
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1473-4. PubMed ID: 16200767
[No Abstract] [Full Text] [Related]
17. Palliative medical oncology.
Joishy SK
Surg Oncol Clin N Am; 2001 Jan; 10(1):203-20. PubMed ID: 11406459
[TBL] [Abstract][Full Text] [Related]
18. Problems in practical clinical hyperthermia: initial experience with the BSD-1000 system for local hyperthermia.
Mella O; Dahl O; Mehus A
Strahlenther Onkol; 1987 Jul; 163(7):436-8. PubMed ID: 3616901
[No Abstract] [Full Text] [Related]
19. Introducing the clinical connection.
Anderson KC
Clin Cancer Res; 2007 Jul; 13(13):3761. PubMed ID: 17606703
[No Abstract] [Full Text] [Related]
20. [Extracorporeally induced systemic hyperthermia for the treatment of cancer].
Nagara H
Kango Gijutsu; 1985 Apr; 31(5):667-8. PubMed ID: 3847567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
